Perspective
Published on 16 Oct 2018
A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis
in Clinical and Diagnostic Microbiology and Immunology
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2018.00360
- 8,875 views
- 17 citations

